{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:06:22Z","timestamp":1793286382376,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010296","name":"James B Pendleton Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["\/ NIAID AI162083"],"award-info":[{"award-number":["\/ NIAID AI162083"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009724","name":"The Roddenberry Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.isci.2026.115334","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:58:08Z","timestamp":1773273488000},"page":"115334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["CGM23 corresponds to a pan-coronavirus lipopeptide inhibitor potently inhibiting virion fusion"],"prefix":"10.1016","volume":"29","author":[{"given":"Yusuke","family":"Matsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Schwarzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Montano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekram W.","family":"Helmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul K.","family":"Suryawanshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha Y.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Angel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Flori","family":"Sassano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunil","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Tarran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5697-1274","authenticated-orcid":false,"given":"Melanie","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warner C.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.115334_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1203\/01.PDR.0000129184.87042.FC","article-title":"SARS: the first pandemic of the 21st century","volume":"56","author":"Cherry","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.isci.2026.115334_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/2049-632X.12166","article-title":"The emergence of the Middle East respiratory syndrome coronavirus","volume":"71","author":"Milne-Price","year":"2014","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.isci.2026.115334_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115334_bib4","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1097\/01.inf.0000188166.17324.60","article-title":"History and recent advances in coronavirus discovery","volume":"24","author":"Kahn","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.isci.2026.115334_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/vex012","article-title":"Global patterns in coronavirus diversity","volume":"3","author":"Anthony","year":"2017","journal-title":"Virus Evol."},{"key":"10.1016\/j.isci.2026.115334_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2026.115334_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41579-020-0394-z","article-title":"Bat-borne virus diversity, spillover and emergence","volume":"18","author":"Letko","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2026.115334_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115334_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.115334_bib10","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months","volume":"385","author":"Levin","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115334_bib11","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115334_bib12","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","article-title":"Covid-19 Breakthrough Infections in Vaccinated Health Care Workers","volume":"385","author":"Bergwerk","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115334_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0140-6736(22)00090-3","article-title":"Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose","volume":"399","author":"Kuhlmann","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.115334_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa2203965","article-title":"Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections","volume":"387","author":"Altarawneh","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115334_bib15","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","article-title":"Long COVID after breakthrough SARS-CoV-2 infection","volume":"28","author":"Al-Aly","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.115334_bib16","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.isci.2026.115334_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature17200","article-title":"Pre-fusion structure of a human coronavirus spike protein","volume":"531","author":"Kirchdoerfer","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115334_bib18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature16988","article-title":"Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer","volume":"531","author":"Walls","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115334_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15092","article-title":"Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains","volume":"8","author":"Yuan","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115334_bib20","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1038\/s41467-020-17371-6","article-title":"Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein","volume":"11","author":"Fan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115334_bib21","article-title":"Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity","volume":"96","author":"Essalmani","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.115334_bib22","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021107821","article-title":"TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells","volume":"40","author":"Koch","year":"2021","journal-title":"Embo j"},{"key":"10.1016\/j.isci.2026.115334_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2026.115334_bib24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41392-021-00558-8","article-title":"Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.115334_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41421-022-00419-w","article-title":"Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies","volume":"8","author":"Zhao","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.isci.2026.115334_bib26","doi-asserted-by":"crossref","first-page":"20836","DOI":"10.1074\/jbc.M400759200","article-title":"Structural characterization of the SARS-coronavirus spike S fusion protein core","volume":"279","author":"Tripet","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.115334_bib27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.115334_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/v14030549","article-title":"A Palmitic Acid-Conjugated, Peptide-Based pan-CoV Fusion Inhibitor Potently Inhibits Infection of SARS-CoV-2 Omicron and Other Variants of Concern","volume":"14","author":"Lan","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.115334_bib29","doi-asserted-by":"crossref","first-page":"e00635-20","DOI":"10.1128\/JVI.00635-20","article-title":"Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity","volume":"94","author":"Zhu","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.115334_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.isci.2026.115334_bib31","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2210990119","article-title":"Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein","volume":"119","author":"Yang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.115334_bib32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41392-021-00698-x","article-title":"SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses","volume":"6","author":"Zhu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.115334_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4580","article-title":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"Xia","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2026.115334_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060302","article-title":"Conjugation of cholesterol to HIV-1 fusion inhibitor C34 increases peptide-membrane interactions potentiating its action","volume":"8","author":"Hollmann","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.115334_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.666","article-title":"Development of potent pan-coronavirus fusion inhibitors with a new design strategy","volume":"5","author":"Zhu","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.isci.2026.115334_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106154","article-title":"Comprehensive preclinical characterization of IPB29, a pan-coronavirus fusion inhibitor under clinical trials","volume":"237","author":"Zhu","year":"2025","journal-title":"Antiviral Res."},{"key":"10.1016\/j.isci.2026.115334_bib37","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1007\/s11427-023-2410-5","article-title":"A pan-coronavirus peptide inhibitor prevents SARS-CoV-2 infection in mice by intranasal delivery","volume":"66","author":"Wu","year":"2023","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.isci.2026.115334_bib38","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41392-021-00712-2","article-title":"Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation","volume":"6","author":"Xia","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.115334_bib39","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.abf4896","article-title":"Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets","volume":"371","author":"de Vries","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.115334_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01249-22","article-title":"Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern","volume":"13","author":"Schmitz","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.isci.2026.115334_bib41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s40425-019-0586-0","article-title":"Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics","volume":"7","author":"Davda","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.isci.2026.115334_bib42","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2026.115334_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-62703-586-6_1","article-title":"Human monoclonal antibodies: the residual challenge of antibody immunogenicity","volume":"1060","author":"Waldmann","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2026.115334_bib44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jviromet.2011.02.002","article-title":"Development of a high-throughput human rhinovirus infectivity cell-based assay for identifying antiviral compounds","volume":"173","author":"Phillips","year":"2011","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.isci.2026.115334_bib45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41577-022-00681-9","article-title":"Omicron entry route","volume":"22","author":"Pia","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.115334_bib46","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115334_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008461","article-title":"Targeting TMPRSS2 and Cathepsin B\/L together may be synergistic against SARS-CoV-2 infection","volume":"16","author":"Padmanabhan","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.isci.2026.115334_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bmc.2018.10.017","article-title":"Cathepsin B: Active site mapping with peptidic substrates and inhibitors","volume":"27","author":"Schmitz","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.isci.2026.115334_bib49","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1515\/hsz-2013-0134","article-title":"Cathepsin K: a unique collagenolytic cysteine peptidase","volume":"394","author":"Novinec","year":"2013","journal-title":"Biol. Chem."},{"key":"10.1016\/j.isci.2026.115334_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12325-017-0648-y","article-title":"The Role of Trypsin:Chymotrypsin in Tissue Repair","volume":"35","author":"Shah","year":"2018","journal-title":"Adv. Ther."},{"key":"10.1016\/j.isci.2026.115334_bib51","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41586-020-2708-8","article-title":"A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures","volume":"586","author":"Dinnon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115334_bib52","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMc2201849","article-title":"Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants","volume":"386","author":"Yu","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115334_bib53","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/s41591-022-01911-2","article-title":"Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa","volume":"28","author":"Tegally","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.115334_bib54","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41564-022-01143-7","article-title":"SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway","volume":"7","author":"Willett","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.isci.2026.115334_bib55","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1107\/S2059798318008318","article-title":"Crystal structure of the post-fusion core of the Human coronavirus 229E spike protein at 1.86 \u00c5 resolution","volume":"74","author":"Yan","year":"2018","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.isci.2026.115334_bib56","doi-asserted-by":"crossref","first-page":"15205","DOI":"10.1021\/bi061686w","article-title":"Core structure of S2 from the human coronavirus NL63 spike glycoprotein","volume":"45","author":"Zheng","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.isci.2026.115334_bib57","unstructured":"ULC, C.C.G. (2025). Molecular Operating Environment (MOE)"},{"key":"10.1016\/j.isci.2026.115334_bib58","article-title":"Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol","volume":"7","author":"Condor Capcha","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.isci.2026.115334_bib59","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41596-021-00491-8","article-title":"Engineering SARS-CoV-2 using a reverse genetic system","volume":"16","author":"Xie","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.isci.2026.115334_bib60","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.abl6184","article-title":"Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles","volume":"374","author":"Syed","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.115334_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012741","article-title":"SARS-CoV-2 evolution balances conflicting roles of N protein phosphorylation","volume":"20","author":"Syed","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2026.115334_bib62","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1038\/s41467-023-37787-0","article-title":"Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6","volume":"14","author":"Taha","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115334_bib63","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1021\/bi00859a010","article-title":"Spectroscopic determination of tryptophan and tyrosine in proteins","volume":"6","author":"Edelhoch","year":"1967","journal-title":"Biochemistry"},{"key":"10.1016\/j.isci.2026.115334_bib64","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1021\/jm0495531","article-title":"Design and NMR characterization of active analogues of compstatin containing non-natural amino acids","volume":"48","author":"Mallik","year":"2005","journal-title":"J. Med. Chem."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226007091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226007091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:40:28Z","timestamp":1790692828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226007091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2589004226007091"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.115334","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CGM23 corresponds to a pan-coronavirus lipopeptide inhibitor potently inhibiting virion fusion","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.115334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115334"}}